Related Experiment Video
Updated: Dec 5, 2025
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
6.2K
Pelvic lymph node dissection in prostate cancer: Laparoscopy is not dead.
A Semaan1, E El Helou1, G Abi Tayeh1
1Departamento de Urología, Hotel-Dieu de France, Beirut, Líbano; Facultad de Medicina, Universidad de Saint Joseph, Beirut, Líbano.
Actas Urologicas Espanolas
|October 18, 2020
Summary
Laparoscopic pelvic lymph node dissection (PLND) for prostate cancer offers a minimally invasive option with faster recovery and fewer complications. Urologists should adopt this effective technique for localized disease.
Area of Science:
- Urology
- Surgical Oncology
Background:
- Pelvic lymph node dissection (PLND) is a key procedure in localized prostate cancer management.
- Open, laparoscopic, and robot-assisted approaches exist, but comparative data is limited.
Purpose of the Study:
- To compare the effectiveness of different pelvic lymph node dissection approaches in prostate cancer treatment.
Main Methods:
- A systematic literature search was conducted for articles published between 1990 and 3000.
- Keywords included "pelvic lymph node dissection" and "pelvic lymphadenectomy" in English or French, with "prostatectomy" in the title.
- Twenty-nine articles were included for qualitative synthesis.
Main Results:
- Laparoscopic PLND is minimally invasive, associated with shorter operative times, less blood loss, reduced pain, and shorter hospital stays compared to open surgery.
- Laparoscopic PLND demonstrates greater cost-effectiveness than robot-assisted PLND.
- Fewer perioperative complications are noted with the laparoscopic approach versus the open approach.
Conclusions:
- Laparoscopic pelvic lymph node dissection is a safe and effective procedure for localized prostate cancer.
- Urologists are encouraged to learn and implement laparoscopic PLND in their practice.
